E-LIB Suche - Ergebnisse für: Micaleff, J.

1

Combining Mcda With Advanced Statistics To Tackle Challenge..:

Goetghebeur, M.M. ; Wagner, M. ; Nikodem, M....
Value in Health. 18 (2015) 3 - p. A12-A13 , 2015

Link: https://doi.org/10.1016/..

2

Structured Frameworks to Increase the Transparency of the A..:

Pignatti, F ; Ashby, D ; Brass, EP...
Clinical Pharmacology & Therapeutics. 98 (2015) 5 - p. 522-533 , 2015

Link: https://doi.org/10.1002/..

3

Pragmatic Mcda Combined With Advanced Pharmacoepidemiology ..:

Goetghebeur, M ; Timmaraju, V. ; Bec, M....
Value in Health. 17 (2014) 3 - p. A31 , 2014

Link: https://doi.org/10.1016/..

4

Use of generic high dose buprenorphine (HDB): About a quali..:

El-Haïk, Y. ; Frauger, E. ; Micaleff, J..
Le Pharmacien Hospitalier et Clinicien. 47 (2012) - p. S79-S80 , 2012

Link: https://doi.org/10.1016/..

5

How to distinguish Guillain‐Barré syndrome from nitrous oxi..:

Fortanier, Etienne ; Berling, Edouard ; Zanin, Adrien...
European Journal of Neurology. 30 (2023) 10 - p. 3296-3306 , 2023

Link: https://doi.org/10.1111/..

6

Reply to letter on What biological markers could be used fo..:

Fortanier, Etienne ; Berling, Edouard ; Zanin, Adrien...
European Journal of Neurology. 31 (2023) 3 - p. , 2023

Link: https://doi.org/10.1111/..

7

Detection of Hyalomma rufipes in a recently arrived asylum ..:

Medialdea-Carrera, Raquel ; Melillo, Tanya ; Micaleff, Cristina.
Ticks and Tick-borne Diseases. 12 (2021) 1 - p. 101571 , 2021

Link: https://doi.org/10.1016/..

8

P4‐077: BLOOD INFLAMMATORY PROFILES MEASURED BY THE ADFLAG®..:

Compagnone, Nathalie A. ; Blanc, Beatrice ; Picamal, Pauline...
Alzheimer's & Dementia. 14 (2018) 7S_Part_28 - p. , 2018

Link: https://doi.org/10.1016/..

9

Pragmatic Multicriteria Decision Analysis (MCDA) Combined W..:

Goetghebeur, Mireille M. ; Wagner, Monika ; Nikodem, Mateusz...
Therapeutic Innovation & Regulatory Science. 50 (2016) 5 - p. 620-631 , 2016

Link: https://doi.org/10.1177/..

10

Recommendations for benefit–risk assessment methodologies a..:

Hughes, Diana ; Waddingham, Ed ; Mt‐Isa, Shahrul...
Pharmacoepidemiology and Drug Safety. 25 (2016) 3 - p. 251-262 , 2016

Link: https://doi.org/10.1002/..

11

Literature review of visual representation of the results o..:

Hallgreen, Christine E. ; Mt‐Isa, Shahrul ; Lieftucht, Alfons...
Pharmacoepidemiology and Drug Safety. 25 (2015) 3 - p. 238-250 , 2015

Link: https://doi.org/10.1002/..

12

Benefit–risk assessment in a post‐market setting: a case st..:

Hallgreen, Christine E. ; van den Ham, Hendrika A. ; Mt‐Isa, Shahrul...
Pharmacoepidemiology and Drug Safety. 23 (2014) 9 - p. 974-983 , 2014

Link: https://doi.org/10.1002/..

13

Balancing benefit and risk of medicines: a systematic revie..:

Mt-Isa, Shahrul ; Hallgreen, Christine E. ; Wang, Nan...
Pharmacoepidemiology and Drug Safety. 23 (2014) 7 - p. 667-678 , 2014

Link: https://doi.org/10.1002/..

14

Weighing benefit–risk of medicines: concepts and approaches:

Mt-Isa, Shahrul ; Tzoulaki, Ioanna ; Callréus, Torbjörn..
Drug Discovery Today: Technologies. 8 (2011) 1 - p. e29-e35 , 2011

Link: https://doi.org/10.1016/..

15

Ascorbic acid inhibits PMP22 expression by reducing cAMP le..:

Kaya, Ferdinand ; Belin, Sophie ; Bourgeois, Patrice...
Neuromuscular Disorders. 17 (2007) 3 - p. 248-253 , 2007

Link: https://doi.org/10.1016/..